Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
samedi, octobre 31
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Elevance Health Inc
ELV
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$420.07
-1.95
-0.46%
Dern. MÀJ: Oct 30, 4:00 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Dividendes
Comparer
Options
Rapport sur les stocks
Elevance Health Financials
Elevance Health (ELV) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test
Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International, Thermo Fisher
Benzinga Insights
PRO
Elevance Health FY2026 Adj EPS expected to be more than $29.00 vs $27.23 Est
Elevance Health (NYSE:ELV) FY2026 expected to be more than $29.00 vs $27.23 Est..
Benzinga Newsdesk
PRO
Elevance Health FY2026 GAAP EPS expected to be more than $22.00 vs $20.74 Est
Elevance Health (NYSE:ELV) FY2026 expected to be more than $22.00 vs $20.74 Est..
Benzinga Newsdesk
PRO
Elevance Health Q3 Adj. EPS $6.99 Beats $4.68 Estimate, Sales $50.440B Beat $49.213B Estimate
Elevance Health (NYSE:ELV) reported quarterly earnings of $6.99 per share which beat the analyst consensus estimate of $4.68 by 49.36 percent. This is a 15.92 percent increase over earnings of $6.03 per share from the
Benzinga Newsdesk
PRO
Elevance Health Affirms FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est
Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..
Benzinga Newsdesk
PRO
Elevance Health Affirms FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est
Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..
Benzinga Newsdesk
